This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Botulinum neurotoxin
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
'''Botulinum neurotoxin''' (CBN) is produced by the bacterium ''Clostridium botulinum''. CBP contains a light (residues 1-440) and a heavy (residues 441-875) chains (LC and HC). CBP LC proteolyzes SNARE substrates which are essential for synaptic vescicle fusion and neurotransmitter release thus causing paralysis. CBP HC acts as a channel and as transmembrane chaperone enabling the passage of the LC into the cytosol. <ref>PMID:15907915</ref> The bacteria produces 8 neurotoxins which differ in their antigens.<br /> | '''Botulinum neurotoxin''' (CBN) is produced by the bacterium ''Clostridium botulinum''. CBP contains a light (residues 1-440) and a heavy (residues 441-875) chains (LC and HC). CBP LC proteolyzes SNARE substrates which are essential for synaptic vescicle fusion and neurotransmitter release thus causing paralysis. CBP HC acts as a channel and as transmembrane chaperone enabling the passage of the LC into the cytosol. <ref>PMID:15907915</ref> The bacteria produces 8 neurotoxins which differ in their antigens.<br /> | ||
| - | *'''Botulinum neurotoxin type A''' is the potent disease agent in botulism.<br /> | + | *'''Botulinum neurotoxin type A''' is the potent disease agent in botulism. See [[Clostridium botulinum neurotoxin serotype A light chain]].<br /> |
*'''Botulinum neurotoxin type B''' is used for treatment of severe spasms in the neck muscles. See [[Clostridium Botulinum Neurotoxin Type B]]. <br /> | *'''Botulinum neurotoxin type B''' is used for treatment of severe spasms in the neck muscles. See [[Clostridium Botulinum Neurotoxin Type B]]. <br /> | ||
*'''Botulinum neurotoxin type C''' induces apoptotic cell death in cerebellar neurons acting in birds, mammals and fish.<br /> | *'''Botulinum neurotoxin type C''' induces apoptotic cell death in cerebellar neurons acting in birds, mammals and fish.<br /> | ||
| Line 37: | Line 37: | ||
*Type A Light Chain | *Type A Light Chain | ||
| - | **[[2g7k]], [[2g7p]], [[2g7q]], [[2imc]], [[3bwi]], [[ | + | **[[2g7k]], [[2g7p]], [[2g7q]], [[2imc]], [[3bwi]], [[3bon]], [[3qix]], [[2ise]], [[2isg]], [[2ish]], [[4ej5]] - CbCBN LC + Zn<br /> |
**[[3bok]] - CbCBN LC <br /> | **[[3bok]] - CbCBN LC <br /> | ||
**[[1e1h]], [[1xtf]], [[4kuf]], [[4el4]], [[4elc]] - CbCBN LC (mutant) + Zn<br /> | **[[1e1h]], [[1xtf]], [[4kuf]], [[4el4]], [[4elc]] - CbCBN LC (mutant) + Zn<br /> | ||
| Line 48: | Line 48: | ||
**[[4ks6]], [[4ktx]] - CbCBN LC (mutant) + inhibitor peptide + Zn<br /> | **[[4ks6]], [[4ktx]] - CbCBN LC (mutant) + inhibitor peptide + Zn<br /> | ||
**[[3ds9]] – CbCBN LC (mutant) + inhibitor peptide + Zn + Ni<br /> | **[[3ds9]] – CbCBN LC (mutant) + inhibitor peptide + Zn + Ni<br /> | ||
| - | **[[3bon]] - CbCBN LC + Zn <br /> | ||
**[[3k3q]] - CbCBN LC + antibody + Zn<br /> | **[[3k3q]] - CbCBN LC + antibody + Zn<br /> | ||
| Line 60: | Line 59: | ||
*Type A Light+Heavy Chain translocation domain | *Type A Light+Heavy Chain translocation domain | ||
| - | **[[2w2d]] - CbCBN LC+HC + Zn<br /> | + | **[[2w2d]], [[3bta]] - CbCBN LC+HC + Zn<br /> |
*'''Type B''' | *'''Type B''' | ||
Revision as of 17:00, 5 January 2016
| |||||||||||
3D structures of botulinum neurotoxin
Updated on 05-January-2016
References
- ↑ Montecucco C, Molgo J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005 Jun;5(3):274-9. PMID:15907915 doi:http://dx.doi.org/10.1016/j.coph.2004.12.006
- ↑ Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998 Oct;5(10):898-902. PMID:9783750 doi:10.1038/2338
